Moreover, studies showed that the increase of sLAG-3 during treatment might predict the worse OS and the clinical responses of patients with HBV-related advanced HCC treated with icariin, [136] and the patients with locally advanced cervical cancer after concurrent chemoradiotherapy [145]. Here, LAG3 is linked to cervical cancer.